Effect of protective colloids on the induction of polymorphic changes in indomethacin agglomerates after solvent evaporation from o/w emulsions
- 1 January 1999
- journal article
- research article
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 16 (1) , 39-47
- https://doi.org/10.1080/026520499289293
Abstract
Indomethacin (IMC) agglomerates were prepared by the solvent evaporation process from o/w emulsions containing different protective colloids in the external aqueous solution. The types of protective colloids inducing the polymorphic transformation of IMC in the agglomerates without wall material were investigated. The composition and its polymorphs were evaluated from the X-ray diffraction patterns, IR spectra and DSC thermograms. The results indicate that when pectin, beta-cyclodextrin, sodium alginate or sodium dodecyl supphase acted as a protective colloid, the respective IMC agglomerates consisted only of the alpha form of IMC. When gelatin or hydroxypropyl methylcellulose was used as a protective colloid, the amorphous, alpha and gamma forms as well as methylene chloride solvates of IMC were found in the IMC agglomerates. There was only methylene chloride solvate of IMC with a small amount of amorphous form in the IMC agglomerates prepared from albumin as a protective colloid, while IMC agglomerates prepared from methylcellulose, polyvinyl alcohol or biosoluble polymer consisted of the mixture of amorphous and alpha forms, and methylene chloride solvate of IMC. When polyvinyl pyrrolidone was applied to act as a protective colloid, the mixture of methylene chloride solvate and gamma form of IMC with less quantity of amorphous form was found in its IMC agglomerates. This strongly suggests that the composition of IMC agglomerates prepared from the solvent evaporation process was significantly influenced by the type of protective colloids used.Keywords
This publication has 10 references indexed in Scilit:
- Functionality of protective colloids affecting the formation, size uniformity and morphology of drug-free polylactic acid microspheresJournal of Microencapsulation, 1998
- Isolation and Solid‐State Characteristics of a New Crystal Form of IndomethacinJournal of Pharmaceutical Sciences, 1992
- A comparison of muencapsulation by various emulsion techniquesInternational Journal of Pharmaceutics, 1990
- Porous Biodegradable Microspheres for Controlled Drug Delivery. I. Assessment of Processing Conditions and Solvent Removal TechniquesPharmaceutical Research, 1988
- Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. I. Methods and morphologyJournal of Microencapsulation, 1987
- Evaluation of biodegradable microspheres prepared by a solvent evaporation process using sodium oleate as emulsifierJournal of Controlled Release, 1986
- Physicochemical characterization of indomethacin polymorphs and the transformation kinetics in ethanol.CHEMICAL & PHARMACEUTICAL BULLETIN, 1985
- Microencapsulation and Controlled Release of Insulin from Polylactic Acid MicrocapsulesBiomaterials, Medical Devices, and Artificial Organs, 1985
- Stability and several physical properties of amorphous and crystalline forms of indomethacin.CHEMICAL & PHARMACEUTICAL BULLETIN, 1980
- Use of Adsorbents in Enhancement of Drug Dissolution IIJournal of Pharmaceutical Sciences, 1972